524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine
Main Authors: | Michael Green, Dmitriy Zamarin, Katherine Panageas, Taha Merghoub, Weiping Zou, Cailian Liu, Jedd Wolchok, Matthew Hellmann, Joseph Chan, Hongyu Shi, Hira Rizvi, Jessica Waninger, Aditi Gupta, Nicholas Ceglia, Viola Allaj, Giulia Zago, Nisarg Shah, Sai Sharma, Marissa Mattar, Yonina Bykov, Corrin Wohlhieter, Fathema Uddin, Inna Khodos, Angel Qin, Vinod Balachandran, Sohrab Shah, Andrew McPherson, Jason Lewis, Justin Perry, Elisa de Stanchina, Triparna Sen, John Poirier, Charles Rudin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
An optimized NGS sample preparation protocol for in vitro CRISPR screens
by: Corrin A. Wohlhieter, et al.
Published: (2021-06-01) -
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
by: Dmitriy Zamarin, et al.
Published: (2014-01-01) -
Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma
by: Sadna Budhu, et al.
Published: (2021-01-01) -
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
by: Fathema Uddin, et al.
Published: (2020-08-01) -
493 Tired and hungry: a potential role for CD47 in T cell exhaustion
by: Taha Merghoub, et al.
Published: (2020-11-01)